This episode currently has no reviews.
Submit ReviewNovavax and Regeneron pop after landing grants from Uncle Sam. SiriusXM buys Stitcher (E.W. Scripps’ podcasting division) for $300 million. Bill Barker analyzes those stories, plus we hop in the wayback machine to revisit The Motley Fool’s (and Bill’s) role in helping the SEC pass “Regulation Fair Disclosure” resulting in a big victory for individual investors.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review